BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 8, 2007
View Archived Issues
BioLineRx Prices $50M IPO, Listing On Tel Aviv Exchange
Israeli drug development firm BioLineRx Ltd. gained a listing on the Tel Aviv Stock Exchange and brought in $50 million in an oversubscribed initial public offering. (BioWorld Today)
Read More
Proacta Completes $35M Series B For Hypoxia Trials
Read More
Encysive Sells $60M In Notes Secured By Argatroban Royalties
Read More
Biogen Idec Testing Targeted MAB In Pivotal CLL Study
Read More
Other News To Note
Read More
U.S. Patent Disclosures
Read More
Clinic Roundup
Read More